Synthace
Synthace is a digital experiment platform built for high-performance life science research and development teams to help them run more powerful experiments and accelerate scientific progress. It allows biologists to design, plan and automate experiments in a single place, then automatically gather structured experiment data and metadata in a unified no-code environment.
Latest Content
Article
How AI Is (So Close to) Transforming Drug Discovery
In this opinion piece, Markus Gershater provides a comprehensive look into the current state and immense potential of artificial intelligence in reshaping the landscape of drug discovery.
Industry Insight
Exploring Key Challenges in Life Science R&D
Technology Networks spoke to Dr. Markus Gershater to learn more about Synthace's Lab automation & experimentation in life science R&D 2023-2024 report, its findings and their significance.
Product News
New Report Reveals Challenges and Opportunities in Life Science R&D Experiments
Synthace has released a comprehensive analyst report that sheds light on the industry challenges faced by researchers and highlights opportunities for improvement.
Industry Insight
How To Build a Data-Centric Future for Biotechnology
In this op-ed, Markus Gershater delves into different aspects of the data we’ll need to generate to help us truly understand the biological systems we deal with.
Article
We Need Biology in the Fight Against Climate Change. But Are We Ready To Use It?
In this opinion piece, Markus Gershater addresses the idea that, while we need biology to help us avoid climate disaster, the truth is, it's nowhere near ready.
Product News
UCL Selects Synthace To Help Make Digital, Cloud-Based Lab Work a Reality
UCL researchers will be leveraging Synthace’s pioneering no-code automation R&D platform to automate routine tasks and design workflows while working from any location as well as utilizing rarely used equipment without the need for custom code.
Industry Insight
Biosciences in 2022: Bioscience Reaps Benefits From the Cloud
Technological innovations brought in as a result of COVID-19 could produce dramatic changes to how we do science. In this insight, Synthace co-founder Markus Gershater previews a cloud-first future for bioscience.
Advertisement
